Vimarsana
Biggest News Aggregation in the World

Page 3 - Mark Rasenick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Rasenick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Rasenick Today - Breaking & Trending Today

Antidepressant Withdrawal Syndrome Linked to Membrane Lipid Raft Signaling - Vimarsana News

Antidepressant Withdrawal Syndrome Linked to Membrane Lipid Raft Signaling

Researchers aim to use technology to better develop personalized treatments for depression.

Study explains why it is difficult to withdraw from certain antidepressants - Vimarsana News

Study explains why it is difficult to withdraw from certain antidepressants

Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications.

Why is it so hard to withdraw from some antidepressants? - Vimarsana News

Why is it so hard to withdraw from some antidepressants?

 E-Mail Researchers at the University of Illinois Chicago are a step closer to discovering why it is so difficult for people to withdraw from some antidepressant medications. The paper "Antidepressants produce persistent Gαs associated signaling changes in lipid rafts following drug withdrawal," published in the journal Molecular Pharmacology, addresses the molecular and cellular mechanisms that cause antidepressant withdrawal syndrome. The study's authors, Mark Rasenick, distinguished professor of physiology and biophysics and psychiatry at UIC and research career scientist at the Jess...

UIC researcher finds potential new way to treat chronic migraine - Vimarsana News

UIC researcher finds potential new way to treat chronic migraine

UIC researcher finds potential new way to treat chronic migraine By discovering a potential new cellular mechanism for migraines, researchers may have also found a new way to treat chronic migraine. Amynah Pradhan, associate professor of psychiatry at the University of Illinois Chicago, is the senior author of the study, whose goal was to identify a new mechanism of chronic migraine, and propose a cellular pathway for migraine therapies. The study, "Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition, is published in eLife. Pradhan, whose rese...